In managing HF, while clinical symptoms and echocardiography are essential, brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-proBNP) are most commonly used biomarkers for monitoring HF. This evidence concerns the gene NPPB and hydrops fetalis.